Provectus Pharmaceuticals, Inc. Share Price OTC Bulletin Board
Equities
PVCT
US74373F1003
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 0.99 82.58 | Sales 2023 | 0.56 46.57 | Capitalization | 4.03Cr 336.28Cr |
---|---|---|---|---|---|
Net income 2022 | -30L -25Cr | Net income 2023 | -30L -25Cr | EV / Sales 2022 | 4,81,21,944 x |
Net Debt 2022 | 21.63L 18Cr | Net Debt 2023 | 29.5L 25Cr | EV / Sales 2023 | 7,75,02,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 27/18/27 |
Eric A. Wachter
FOU | Founder | 61 | 01/02/01 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01/02/01 |
John W. Lacey
BRD | Director/Board Member | 76 | 27/18/27 |
President | 55 | 03/17/03 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock